{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T19:09:12Z","timestamp":1769972952561,"version":"3.49.0"},"reference-count":92,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2013,2,12]],"date-time":"2013-02-12T00:00:00Z","timestamp":1360627200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch. Immunol. Ther. Exp."],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s00005-013-0219-0","type":"journal-article","created":{"date-parts":[[2013,2,11]],"date-time":"2013-02-11T11:47:42Z","timestamp":1360583262000},"page":"193-201","source":"Crossref","is-referenced-by-count":40,"title":["Immune Exhaustion and Immune Senescence: Two Distinct Pathways for HBV Vaccine Failure During HCV and\/or HIV Infection"],"prefix":"10.2478","volume":"61","author":[{"given":"Zhi Q.","family":"Yao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan P.","family":"Moorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2013,2,12]]},"reference":[{"key":"219_CR1","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1111\/j.1600-0463.2005.apm_191.x","volume":"113","author":"B Albarran","year":"2005","unstructured":"Albarran B, Goncalves B, Salmen B et al (2005) Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. APMIS 113:526\u2013535","journal-title":"APMIS"},{"key":"219_CR2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nri818","volume":"2","author":"WS Alexander","year":"2002","unstructured":"Alexander WS (2002) Suppressors of cytokine signaling (SOCS) in the immune system. Nat Rev Immunol 2:410\u2013416","journal-title":"Nat Rev Immunol"},{"key":"219_CR3","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.biologicals.2011.09.014","volume":"40","author":"JP Allain","year":"2012","unstructured":"Allain JP, Canotti D (2012) Hepatitis B virus in transfusion medicine: still a problem? Biologicals 40:180\u2013186","journal-title":"Biologicals"},{"key":"219_CR4","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.exger.2006.12.003","volume":"42","author":"V Appay","year":"2007","unstructured":"Appay V, Almeida JR, Sauce D et al (2007) Accelerated immune senescence and HIV-1 infection. Exp Gerontol 42:432\u2013437","journal-title":"Exp Gerontol"},{"key":"219_CR5","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1038\/nature01368","volume":"421","author":"CJ Bakkenist","year":"2003","unstructured":"Bakkenist CJ, Kastan MB (2003) DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499\u2013506","journal-title":"Nature"},{"key":"219_CR6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nature04444","volume":"439","author":"DL Barber","year":"2006","unstructured":"Barber DL, Wherry EJ, Asopust DM et al (2006) Restoring function in exhausted CD8 T cells during chronic viral infection. Nature 439:682\u2013687","journal-title":"Nature"},{"key":"219_CR7","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.vaccine.2005.08.058","volume":"24","author":"T Bauer","year":"2006","unstructured":"Bauer T, Jilg W (2006) Hepatitis B surface antigen-specific T and B cell memory in individuals who had lost protective antibodies after hepatitis B vaccination. Vaccine 24:572\u2013577","journal-title":"Vaccine"},{"key":"219_CR8","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1002\/lt.21061","volume":"13","author":"T Bauer","year":"2007","unstructured":"Bauer T, Gunther M, Bienzie I et al (2007) Vaccination against hepatitis B in liver transplant receipients: pilot analysis of cellular immune response shows evidence of HBsAg-specific regulatory T cells. Liver Transpl 13:434\u2013442","journal-title":"Liver Transpl"},{"key":"219_CR9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1056\/NEJM198703053161015","volume":"316","author":"R Biggar","year":"1987","unstructured":"Biggar R, Goedert J, Hoofnagle J (1987) Accelerated loss of antibody to hepatitis B surface antigen among immunodeficient homosexual men infected with HIV. N Engl J Med 316:630\u2013631","journal-title":"N Engl J Med"},{"key":"219_CR10","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/infdis\/160.4.577","volume":"160","author":"N Bodsworth","year":"1989","unstructured":"Bodsworth N, Donovan B, Nightingale B (1989) The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B. a study of 150 homosexual men. J Infect Dis 160:577\u2013582","journal-title":"J Infect Dis"},{"key":"219_CR11","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1093\/infdis\/163.5.1138","volume":"163","author":"NJ Bodsworth","year":"1991","unstructured":"Bodsworth NJ, Cooper DA, Donovan B (1991) The influence of human immunodeficiency virus type 1 infection on the development of the hepatitis B virus carrier state. J Infect Dis 163:1138\u20131140","journal-title":"J Infect Dis"},{"key":"219_CR12","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"C Boni","year":"2007","unstructured":"Boni C, Fisicaro P, Valdatta C et al (2007) Charaterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol 81:4215\u20134225","journal-title":"J Virol"},{"key":"219_CR13","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1101\/gad.1067403","volume":"17","author":"EJ Brown","year":"2003","unstructured":"Brown EJ, Baltimore D (2003) Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 17:615\u2013628","journal-title":"Genes Dev"},{"key":"219_CR14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/00004836-199201000-00007","volume":"14","author":"M Bruguera","year":"1992","unstructured":"Bruguera M, Cremades M, Salinas R et al (1992) Impaired response to recombinant hepatitis B vaccine in HIV-infected persons. J Clin Gastroenterol 14:27\u201330","journal-title":"J Clin Gastroenterol"},{"key":"219_CR15","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/nri1349","volume":"4","author":"L Chen","year":"2004","unstructured":"Chen L (2004) Co-inhibitory molecules of the B7-CD28 family in the control of T-cell immunity. Nat Rev Immunol 4:336\u2013347","journal-title":"Nat Rev Immunol"},{"key":"219_CR16","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.cld.2007.08.007","volume":"11","author":"S Cheruvu","year":"2007","unstructured":"Cheruvu S, Marks K, Talal AH (2007) Understanding and management of hepatitis B\/HIV and hepatitis B\/hepatitis C virus coinfection. Clin Liver Dis 11:917\u2013943","journal-title":"Clin Liver Dis"},{"key":"219_CR17","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1182\/blood-2004-08-3049","volume":"106","author":"MM Chong","year":"2005","unstructured":"Chong MM, Metcalf D, Jamieson E et al (2005) Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 106:1668\u20131675","journal-title":"Blood"},{"key":"219_CR18","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7326\/0003-4819-109-2-101","volume":"109","author":"A Collier","year":"1988","unstructured":"Collier A, Corey L, Murphy V et al (1988) Antibody to human immunodeficiency virus (HIV) and suboptimal response to hepatitis B vaccination. Ann Intern Med 109:101\u2013105","journal-title":"Ann Intern Med"},{"key":"219_CR19","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.4049\/jimmunol.179.3.1979","volume":"179","author":"M D\u2019Souza","year":"2007","unstructured":"D\u2019Souza M, Fontenot AP, Mack DG et al (2007) Programmed death 1 expression on HIV-specific CD4+ T cells is driven by viral replication and associated with T cell dysfunction. J Immunol 179:1979\u20131987","journal-title":"J Immunol"},{"key":"219_CR20","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/sj.gene.6363792","volume":"2","author":"A Silvestri De","year":"2001","unstructured":"De Silvestri A, Pasi A, Martinetti M et al (2001) Family study of non-responsiveness to hepatitis B vaccine confirms the importance of HLA class III C4A locus. Genes Immun 2:367\u2013372","journal-title":"Genes Immun"},{"issue":"15","key":"219_CR21","doi-asserted-by":"crossref","first-page":"520","DOI":"10.4049\/jimmunol.154.2.520","volume":"154","author":"I Desombere","year":"1995","unstructured":"Desombere I, Hauser P, Rossau R et al (1995) Non responders to hepatitis B vaccine can present evelope particles to T lymphocytes. J Immunol 154(15):520\u2013529","journal-title":"J Immunol"},{"key":"219_CR22","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2249.2004.02749.x","volume":"140","author":"I Desombere","year":"2005","unstructured":"Desombere I, Cao P, Gijbels Y et al (2005) Non-responsiveness to hepatitis B surface antigen vaccines is not caused by defective antigen presentation or a lack of B7 co-stimulation. Clin Exp Immunol 140:126\u2013137","journal-title":"Clin Exp Immunol"},{"key":"219_CR23","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm0902-1039c","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR et al (2002) Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med 8:793\u2013800","journal-title":"Nat Med"},{"key":"219_CR24","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1111\/j.1365-2893.2008.00982.x","volume":"15","author":"AS Duberg","year":"2008","unstructured":"Duberg AS, Torner A, Daviosdottir L et al (2008) Cause of death in individuals with chronic HBV and\/or HCV infection, a nationwide community-based register study. J Viral Hepat 15:538\u2013550","journal-title":"J Viral Hepat"},{"key":"219_CR25","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1086\/590150","volume":"47","author":"RB Effros","year":"2008","unstructured":"Effros RB, Fletcher CV, Gebo K et al (2008) Aging and infectious diseases: workshop on HIV infection and aging: what is known and future research directions. Clin Infect Dis 47:542\u2013553","journal-title":"Clin Infect Dis"},{"key":"219_CR26","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1172\/JCI16156","volume":"111","author":"PJ Egan","year":"2003","unstructured":"Egan PJ, Lawlor KE, Alexander WS et al (2003) Suppressor of cytokine signaling-1 regulates acute inflammatory arthritis and T cell activation. J Clin Invest 111:915\u2013924","journal-title":"J Clin Invest"},{"key":"219_CR27","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1097\/00002030-199206000-00008","volume":"6","author":"A Eskild","year":"1992","unstructured":"Eskild A, Magnus P, Petersen G et al (1992) Hepatitis B antibodies in HIV-infected homosexual men are associated with more rapid progression to AIDS. AIDS 6:571\u2013574","journal-title":"AIDS"},{"key":"219_CR28","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2174\/157016211797636008","volume":"9","author":"S Ferrando-Mart\u00ednez","year":"2011","unstructured":"Ferrando-Mart\u00ednez S, Ruiz-Mateos E, Romero-S\u00e1nchez MC et al (2011) HIV infection-related premature immunosenescence: high rates of immune exhaustion after short time infection. Curr HIV Res 9:289\u2013294","journal-title":"Curr HIV Res"},{"key":"219_CR29","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jmv.20992","volume":"79","author":"P Filippini","year":"2007","unstructured":"Filippini P, Coppola N, Pisapia R et al (2007) Virological and clinical aspects of HBV-HCV coinfection in HIV positive patients. J Med Virol 79:1679\u20131685","journal-title":"J Med Virol"},{"key":"219_CR30","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1086\/344271","volume":"35","author":"DN Fisman","year":"2002","unstructured":"Fisman DN, Agrawal D, Leder K (2002) The effect of age on immunologic response to recombinant hepatitis B vaccine: a meta-analysis. Clin Infect Dis 35:1368\u20131375","journal-title":"Clin Infect Dis"},{"key":"219_CR31","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1089\/vim.2010.0010","volume":"23","author":"AD Frazier","year":"2010","unstructured":"Frazier AD, Zhang CL, Ni L et al (2010) Program death-1 pathway affects suppressor of cytokine signaling-1 expression in T cells during hepatitis C infection. Viral Immunol 23:487\u2013495","journal-title":"Viral Immunol"},{"key":"219_CR32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/00002030-199705000-00007","volume":"11","author":"RJ Gilson","year":"1997","unstructured":"Gilson RJ, Hawkins AE, Beecham MR et al (1997) Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11:597\u2013606","journal-title":"AIDS"},{"key":"219_CR33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1002\/hep.20716","volume":"41","author":"A Godkin","year":"2005","unstructured":"Godkin A, Davenport M, Hill AV (2005) Molecular analysis of HLA class II associations with hepatitis B virus clearance and vaccine nonresponsiveness. Hepatology 41:1383\u20131390","journal-title":"Hepatology"},{"key":"219_CR34","doi-asserted-by":"crossref","first-page":"9249","DOI":"10.1128\/JVI.00409-07","volume":"81","author":"L Golden-Mason","year":"2007","unstructured":"Golden-Mason L, Palmer B, Klarquist J et al (2007) Upregulation of PD-1 expression on circulating and intrahepatic hepatitis C virus-specific CD8+ T cells associated with reversible immune dysfunction. J Virol 81:9249\u20139258","journal-title":"J Virol"},{"key":"219_CR35","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.virol.2004.04.042","volume":"326","author":"L Goncalves","year":"2004","unstructured":"Goncalves L, Albarran B, Salmen S et al (2004) The nonresponse to hepatitis B vaccination is associated with impaired lymphocyte activation. Virology 326:20\u201328","journal-title":"Virology"},{"key":"219_CR36","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1084\/jem.20082429","volume":"205","author":"DA Hafler","year":"2008","unstructured":"Hafler DA, Kuchroo V (2008) TIMs: central regulators of immune responses. J Exp Med 205:2699\u20132701","journal-title":"J Exp Med"},{"key":"219_CR37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0168-8278(02)00205-2","volume":"37","author":"T Hohler","year":"2002","unstructured":"Hohler T, Stradmann-Bellinghausen B, Starke R et al (2002) C4A deficiency and nonresponse to hepatitis B vaccination. J Hepatol 37:387\u2013392","journal-title":"J Hepatol"},{"key":"219_CR38","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/clinids\/18.3.339","volume":"18","author":"J Horvath","year":"1994","unstructured":"Horvath J, Raffanti S (1994) Clinical aspects of the interactions between human immunodeficiency virus and the hepatotropic viruses. Clin Infect Dis 18:339\u2013410","journal-title":"Clin Infect Dis"},{"key":"219_CR39","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1084\/jem.20022235","volume":"198","author":"Y Iwai","year":"2003","unstructured":"Iwai Y, Terawaya S, Ikegawa M et al (2003) PD-1 inhibits antiviral immunity at the effector phase in the liver. J Exp Med 198:39\u201350","journal-title":"J Exp Med"},{"key":"219_CR40","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1016\/S0264-410X(02)00397-3","volume":"20","author":"P Jacques","year":"2002","unstructured":"Jacques P, Moens G, Desombere I et al (2002) The immunogenicity and reacogenicity profile of a candidate hepatitis B vaccine in an adult vaccine non-responder population. Vaccine 20:3644\u20133649","journal-title":"Vaccine"},{"key":"219_CR41","doi-asserted-by":"crossref","first-page":"14733","DOI":"10.1073\/pnas.1009731107","volume":"107","author":"HT Jin","year":"2010","unstructured":"Jin HT, Anderson AC, Tan WG et al (2010) Cooperation of Tim-3 and PD-1 in CD8 T-cell exhaustion during chronic viral infection. Proc Natl Acad Sci USA 107:14733\u201314738","journal-title":"Proc Natl Acad Sci USA"},{"key":"219_CR42","doi-asserted-by":"crossref","first-page":"2763","DOI":"10.1084\/jem.20081398","volume":"205","author":"RB Jones","year":"2008","unstructured":"Jones RB, Ndhlovu LC, Barbour JD et al (2008) Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection. J Exp Med 205:2763\u20132779","journal-title":"J Exp Med"},{"key":"219_CR43","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/S1473-3099(02)00315-8","volume":"2","author":"JH Kao","year":"2002","unstructured":"Kao JH, Chen DS (2002) Global control of hepatitis B virus infection. Lancet Infect Dis 2:395\u2013403","journal-title":"Lancet Infect Dis"},{"issue":"(Suppl 10A)","key":"219_CR44","doi-asserted-by":"crossref","first-page":"21S","DOI":"10.1016\/j.amjmed.2005.07.013","volume":"118","author":"EB Keeffe","year":"2005","unstructured":"Keeffe EB (2005) Acute hepatitis A and B in patients with chronic liver disease: prevention through vaccination. Am J Med 118((Suppl 10A)):21S\u201327S","journal-title":"Am J Med"},{"key":"219_CR45","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1086\/377135","volume":"188","author":"SE Kellerman","year":"2003","unstructured":"Kellerman SE, Hanson DL, McNaghten AD et al (2003) Prevalence of chronic hepatitis B and incidence of acute hepatitis B infection in human immunodeficiency virus-infected subjects. J Infect Dis 188:571\u2013577","journal-title":"J Infect Dis"},{"key":"219_CR46","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1074-7613(04)00116-5","volume":"20","author":"SJ Khoury","year":"2004","unstructured":"Khoury SJ, Sayegh MH (2004) The role of the new negative T cell costimulatory pathways in regulating autoimmunity. Immunity 20:529\u2013538","journal-title":"Immunity"},{"key":"219_CR47","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1016\/S0264-410X(02)00626-6","volume":"21","author":"MJ Kim","year":"2003","unstructured":"Kim MJ, Nafziger AN, Harro CD et al (2003) Revaccination of healthy nonreasponders with hepatitis B vaccine and prediction of seroprotection response. Vaccine 21:1174\u20131179","journal-title":"Vaccine"},{"key":"219_CR48","first-page":"1050","volume":"34","author":"SL Klein","year":"2012","unstructured":"Klein SL (2012) Sex influences immune responses to viruses, and efficacy of prophylaxis and treatments for viral diseases. Bio Essays 34:1050\u20131059","journal-title":"Bio Essays"},{"key":"219_CR49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/S1473-3099(10)70049-9","volume":"10","author":"SL Klein","year":"2010","unstructured":"Klein SL, Jedlicka A, Pekosz A (2010) The Xs and Y of immune responses to viral vaccines. Lancet Infect Dis 10:338\u2013349","journal-title":"Lancet Infect Dis"},{"key":"219_CR50","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1007\/s10620-009-0867-4","volume":"54","author":"ES Kramer","year":"2009","unstructured":"Kramer ES, Hofmann C, Smith PG et al (2009) Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis. Dig Dis Sci 54:2016\u20132025","journal-title":"Dig Dis Sci"},{"key":"219_CR51","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/nri1111","volume":"3","author":"VK Kuchroo","year":"2003","unstructured":"Kuchroo VK, Umetsu DT, DeKruyff RH et al (2003) The TIM gene family: emerging roles in immunity and disease. Nat Rev Immunol 3:454\u2013462","journal-title":"Nat Rev Immunol"},{"key":"219_CR52","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1399-0039.1998.tb03058.x","volume":"52","author":"A Lango-Warensjo","year":"1998","unstructured":"Lango-Warensjo A, Cardell K, Lindblom B (1998) Haplotypes comprising subtypes of the DQB1*06 allele direct the antibody response with hepatitis B surface antigen. Tissue Antigens 52:374\u2013380","journal-title":"Tissue Antigens"},{"key":"219_CR53","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1093\/infdis\/158.3.666","volume":"158","author":"Y Lazizi","year":"1988","unstructured":"Lazizi Y, Grangeot-Keros L, Delfraissy J et al (1988) Reappearance of hepatitis B virus in immune patients infected with the human immunodeficiency virus type 1. J Infect Dis 158:666\u2013667","journal-title":"J Infect Dis"},{"key":"219_CR54","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1749-6632.2011.06297.x","volume":"1247","author":"S Saux Le","year":"2012","unstructured":"Le Saux S, Weyand CM, Goronzy JJ (2012) Mechanisms of immune senescence: lessons from models of accelerated immune aging. Ann NY Acad Sci 1247:69\u201382","journal-title":"Ann NY Acad Sci"},{"key":"219_CR55","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2567.2010.03382.x","volume":"132","author":"CJ Ma","year":"2011","unstructured":"Ma CJ, Ni L, Zhang Y et al (2011) PD-1 negatively regulates IL-12 expression by limiting STAT-1 phosphorylation in monocytes\/macrophages during chronic hepatitis C infection. Immunology 132:421\u2013431","journal-title":"Immunology"},{"key":"219_CR56","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/jmv.21762","volume":"82","author":"LC Macedo","year":"2010","unstructured":"Macedo LC, Isolani AP, Visentainer JE et al (2010) Association of cytokine genetic polymorphrisms with the humoral immune response to recombinant vaccine against HBV in infants. J Med Virol 82:929\u2013933","journal-title":"J Med Virol"},{"key":"219_CR57","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1086\/429298","volume":"191","author":"A Malaspina","year":"2005","unstructured":"Malaspina A, Moir S, Orsega SM et al (2005) Compromised B cell responses to influenza vaccination in HIV-infected individuals. J Infect Dis 191:1442\u20131450","journal-title":"J Infect Dis"},{"key":"219_CR58","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1172\/JCI43127","volume":"120","author":"RH McMahan","year":"2010","unstructured":"McMahan RH, Golden-Mason L, Nishimura MI et al (2010) Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity. J Clin Invest 120:4546\u20134557","journal-title":"J Clin Invest"},{"key":"219_CR59","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1111\/j.1365-2567.2009.03106.x","volume":"128","author":"JP Moorman","year":"2009","unstructured":"Moorman JP, Dong ZP, Ni L et al (2009) Abnormal B lymphocyte activation associated with TALL-1 overexpression and SOCS-1 deregulation in chronic HCV infection. Immunology 128:227\u2013235","journal-title":"Immunology"},{"key":"219_CR60","doi-asserted-by":"crossref","first-page":"3169","DOI":"10.1016\/j.vaccine.2011.02.052","volume":"29","author":"JP Moorman","year":"2011","unstructured":"Moorman JP, Zhang CL, Ni L et al (2011) Impaired hepatitis B vaccine responses during chronic hepatitis C infection: involvement of the PD-1 pathway in regulating CD4+ T cell responses. Vaccine 29:3169\u20133176","journal-title":"Vaccine"},{"key":"219_CR61","doi-asserted-by":"crossref","first-page":"755","DOI":"10.4049\/jimmunol.1200162","volume":"189","author":"JP Moorman","year":"2012","unstructured":"Moorman JP, Wang JM, Zhang Y et al (2012) Tim-3 controls regulatory and effector T cell balance during HCV Infection. J Immunol 189:755\u2013766","journal-title":"J Immunol"},{"key":"219_CR62","doi-asserted-by":"crossref","first-page":"5405","DOI":"10.1073\/pnas.090084797","volume":"97","author":"Y Morita","year":"2000","unstructured":"Morita Y, Naka T, Kawazoe Y et al (2000) Signals transducers and activators of transcription (STAT)-indueced STAT inhibitor (SS-1)\/suppressor of cytokine signaling-1 (SOCS-1) suppreses tumor necrosis factor \u03b1-induced cell death in fibroblasts. Proc Natl Acad Sci USA 97:5405\u20135410","journal-title":"Proc Natl Acad Sci USA"},{"key":"219_CR63","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/icb.2010.121","volume":"89","author":"L Ni","year":"2010","unstructured":"Ni L, Ma CJ, Zhang Y et al (2010) PD-1 modulates Regulatory T cells and suppresses T cell responses in HCV-associated Lymphoma. Immunol Cell Biol 89:535\u2013539","journal-title":"Immunol Cell Biol"},{"key":"219_CR64","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S1471-4906(01)01888-9","volume":"22","author":"H Nishimura","year":"2001","unstructured":"Nishimura H, Honjo T (2001) PD-1: an inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol 22:265\u2013268","journal-title":"Trends Immunol"},{"key":"219_CR65","doi-asserted-by":"crossref","first-page":"5967","DOI":"10.1016\/j.vaccine.2008.08.054","volume":"26","author":"J Nystrom","year":"2008","unstructured":"Nystrom J, Cardell K, Bjornsdottir TB et al (2008) Improved cell mediated immune responses after successful re-vaccination of non-responders to the hepatitis B virus surface antigen (HBsAg) vaccine using the combined hepatitis A and B vaccine. Vaccine 26:5967\u20135972","journal-title":"Vaccine"},{"key":"219_CR66","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1093\/intimm\/dxm057","volume":"19","author":"T Okazaki","year":"2007","unstructured":"Okazaki T, Honjo T (2007) PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 19:813\u2013824","journal-title":"Int Immunol"},{"key":"219_CR67","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/hep.510310237","volume":"31","author":"F Rahman","year":"2000","unstructured":"Rahman F, Dahmen A, Herzog-Hauff S et al (2000) Cellular and humoral immune responses induced by intradermal or intramuscular vaccination with a major hepatitis B surface antigen. Hepatology 31:521\u2013527","journal-title":"Hepatology"},{"key":"219_CR68","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1016\/S0264-410X(96)00134-X","volume":"14","author":"JM Ramon","year":"1996","unstructured":"Ramon JM, Bou R, Oromi J (1996) Low-dose intramuscular revaccination against hepatitis B. Vaccine 14:1647\u20131650","journal-title":"Vaccine"},{"key":"219_CR69","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1086\/375841","volume":"37","author":"MC Rodriguez-Barradas","year":"2003","unstructured":"Rodriguez-Barradas MC, Alexandraki I, Nazir T et al (2003) Response of human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy to vaccination with 23-valent pneumococcal polysaccharide vaccine. Clin Infect Dis 37:438\u2013447","journal-title":"Clin Infect Dis"},{"key":"219_CR70","doi-asserted-by":"crossref","first-page":"e44611","DOI":"10.1371\/journal.pone.0044611","volume":"7","author":"C Rossi","year":"2012","unstructured":"Rossi C, Shrier I, Marshall L et al (2012) Seroprevalence of chronic hepatitis B virus infection and prior immunity in immigrants and refugees: a systematic review and meta-analysis. PLoS One 7:e44611","journal-title":"PLoS One"},{"key":"219_CR71","doi-asserted-by":"crossref","first-page":"e12273","DOI":"10.1371\/journal.pone.0012273","volume":"5","author":"KK Ryckman","year":"2010","unstructured":"Ryckman KK, Fielding K, Hill AV et al (2010) Host genetic factors and vaccine-induced immunity to HBV infection: haplotype analysis. PLoS One 5:e12273","journal-title":"PLoS One"},{"key":"219_CR72","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/BF00163994","volume":"41","author":"M Salazar","year":"1995","unstructured":"Salazar M, Deulofeut H, Granja C et al (1995) Normal HBsAg presentation and T cell defect in the immune response of nonresponders. Immunogenetics 41:366\u2013374","journal-title":"Immunogenetics"},{"key":"219_CR73","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1146\/annurev.biochem.73.011303.073723","volume":"73","author":"A Sancar","year":"2004","unstructured":"Sancar A, Lindsey-Boltz LA, Unsal-Ka\u00e7maz K et al (2004) Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu Rev Biochem 73:39\u201385","journal-title":"Annu Rev Biochem"},{"key":"219_CR74","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1468-1293.2007.00473.x","volume":"8","author":"SD Shafran","year":"2007","unstructured":"Shafran SD, Mashinter LD, Lindemulder A et al (2007) Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine. HIV Med 8:295\u2013299","journal-title":"HIV Med"},{"key":"219_CR75","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nri727","volume":"2","author":"AH Sharpe","year":"2002","unstructured":"Sharpe AH, Freeman GJ (2002) The B7-CD28 superfamily. Nat Rev Immunol 2:116\u2013126","journal-title":"Nat Rev Immunol"},{"key":"219_CR76","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJMoa1007644","volume":"364","author":"SL Stramer","year":"2011","unstructured":"Stramer SL, Wend U, Candotti D et al (2011) Nucleic acid testing to detect HBV infection in blood donors. N Engl J Med 364:236\u2013247","journal-title":"N Engl J Med"},{"key":"219_CR77","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(02)11913-1","volume":"360","author":"CL Thio","year":"2002","unstructured":"Thio CL, Seaberg EC, Skolasky RJ et al (2002) HIV-1, hepatitis B virus, and risk for liver-related mortality in the Multicenter Cohort Study (MACS). Lancet 360:1921\u20131926","journal-title":"Lancet"},{"key":"219_CR78","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/hep.20025","volume":"39","author":"M Torbenson","year":"2004","unstructured":"Torbenson M, Kannangai R, Astemborski J et al (2004) High prevalence of occult hepatitis B in Baltimore injection drug users. Hepatology 39:51\u201357","journal-title":"Hepatology"},{"key":"219_CR79","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0264-410X(00)00205-X","volume":"19","author":"IJ Tsai","year":"2000","unstructured":"Tsai IJ, Chang MH, Chen HL et al (2000) Immunogenicity and reactogenicity of the combined hepatitis A and B vaccine in young adults. Vaccine 19:437\u2013441","journal-title":"Vaccine"},{"key":"219_CR80","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.1002\/eji.201040340","volume":"40","author":"B Vali","year":"2010","unstructured":"Vali B, Jones RB, Sakhdari A et al (2010) HCV-specific T cells in HCV\/HIV co-infection show elevated frequencies of dual Tim-3\/PD-1 expression that correlate with liver disease progression. Eur J Immunol 40:2493\u20132505","journal-title":"Eur J Immunol"},{"key":"219_CR81","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s10238-007-0127-x","volume":"7","author":"MA Verkade","year":"2007","unstructured":"Verkade MA, van Druningen CJ, de Op Hoek CT et al (2007) Decreased antigen-specific T cell proliferation by moDC among hepatitis B vaccine non-responders on haemodialysis. Clin Exp Med 7:65\u201371","journal-title":"Clin Exp Med"},{"key":"219_CR82","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.167.9.4838","volume":"167","author":"D Voehringer","year":"2001","unstructured":"Voehringer D, Blaser C, Brawand P et al (2001) Viral infections induce abundant numbers of senescent CD8 T cells. J Immunol 167:4838\u20134843","journal-title":"J Immunol"},{"key":"219_CR83","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1001\/archinte.166.15.1632","volume":"166","author":"R Weber","year":"2006","unstructured":"Weber R, Sabin CA, Friis-Moller N et al (2006) Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D Study. Arch Intern Med 166:1632\u20131641","journal-title":"Arch Intern Med"},{"key":"219_CR84","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0042-6822(03)00419-7","volume":"314","author":"ZQ Yao","year":"2003","unstructured":"Yao ZQ, Eisen-Vandervelde A, Ray S et al (2003) HCV core\/gC1qR interaction arrests T cell cycle progression through stabilization of the cell cycle inhibitor p27kip1. Virology 314:271\u2013282","journal-title":"Virology"},{"key":"219_CR85","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1089\/vim.2006.0096","volume":"20","author":"ZQ Yao","year":"2007","unstructured":"Yao ZQ, King E, Prayther D et al (2007) T cell dysfunction by hepatitis C virus core protein involves PD-1\/PDL-1 signaling. Viral Immunol 20:276\u2013287","journal-title":"Viral Immunol"},{"key":"219_CR86","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2567.2008.02829.x","volume":"125","author":"ZQ Yao","year":"2008","unstructured":"Yao ZQ, Prayther D, Trabu C et al (2008) Differential regulation of SOCS-1 signaling in T and B lymphocytes by HCV core protein. Immunology 125:197\u2013207","journal-title":"Immunology"},{"key":"219_CR87","first-page":"243","volume":"40","author":"ZQ Yao","year":"2010","unstructured":"Yao ZQ, Ni L, Zhang Y et al (2010) Differential regulation of T and B lymphocytes by PD-1 and SOCS-1 signaling in hepatitis C virus-associated non-Hodgkin\u2019s lymphoma. Immunol Invest 40:243\u2013264","journal-title":"Immunol Invest"},{"key":"219_CR88","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0168-8278(98)80198-0","volume":"28","author":"JP Zarski","year":"1998","unstructured":"Zarski JP, Bohn B, Bastie A et al (1998) Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 28:27\u201333","journal-title":"J Hepatol"},{"key":"219_CR89","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.4049\/jimmunol.1002006","volume":"186","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Ma CJ, Ni L et al (2011a) Crosstalk between PD-1 and SOCS-1 in HCV core-mediated IL-12 suppression. J Immunol 186:3093\u20133103","journal-title":"J Immunol"},{"key":"219_CR90","doi-asserted-by":"crossref","first-page":"e19664","DOI":"10.1371\/journal.pone.0019664","volume":"6","author":"Y Zhang","year":"2011","unstructured":"Zhang Y, Ma CJ, Wu XY et al (2011b) Tim-3 negatively regulates IL-12 production by monocytes in HCV infection. PLoS One 6:e19664","journal-title":"PLoS One"},{"key":"219_CR91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1189\/jlb.1010591","volume":"91","author":"Y Zhang","year":"2012","unstructured":"Zhang Y, Cheng J, Ma CJ et al (2012) Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes. J Leukoc Biol 91:189\u2013196","journal-title":"J Leukoc Biol"},{"key":"219_CR92","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1126\/science.1083430","volume":"300","author":"L Zou","year":"2003","unstructured":"Zou L, Elledge SJ (2003) Sensing DNA damage through ATRIP recognition of RPA-ssDNA complexes. Science 300:1542\u20131548","journal-title":"Science"}],"container-title":["Archivum Immunologiae et Therapiae Experimentalis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0219-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00005-013-0219-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00005-013-0219-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,2]],"date-time":"2024-01-02T20:47:40Z","timestamp":1704228460000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00005-013-0219-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,2,12]]},"references-count":92,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["219"],"URL":"https:\/\/doi.org\/10.1007\/s00005-013-0219-0","relation":{},"ISSN":["0004-069X","1661-4917"],"issn-type":[{"value":"0004-069X","type":"print"},{"value":"1661-4917","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,2,12]]}}}